More strict production hygiene standards eyed

Buildings and facilities used in the manufacture of cephalosporins and cytotoxic agents should be separated from other production areas to minimize potential contamination, according to the Korea Food and Drug Administration.

Under the facilities rules to be revised, the separate buildings and facilities should be located and constructed to facilitate, cleaning, maintenance and operations as...